Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma-Reference-Cited by-同舟云学术

Risk Factors for Nonsynchronous Second Primary Malignancy and Related Death in Patients with Differentiated Thyroid Carcinoma

Published:2011-05-15 Issue:13 Volume:18 Page:3559-3565
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Lang Brian Hung-Hin,Wong Kai Pun

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://www.springerlink.com/index/pdf/10.1245/s10434-011-1777-1

Reference22 articles.

1. Cancer incidence and mortality in Hong Kong 1983-2006. Hong Kong Cancer Registry, Hong Kong. http://www3.ha.org.hk/cancereg/e_stat.asp . Accessed on 15 Jan 2010.

2. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008;19:585–93.

3. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Prognostic factors in papillary and follicular thyroid carcinoma: implications for cancer staging. Ann Surg Oncol. 2007;14:730–8.

4. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192–202.

5. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93:504–15.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis through propensity score matching in thyroid cancer: unveiling the impact of multiple malignancies;Frontiers in Endocrinology;2024-06-04

2. Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive‐resistant differentiated thyroid cancer;Cancer Medicine;2022-10

3. Non-thyroidal second primary malignancy in papillary thyroid cancer patients;European Thyroid Journal;2022-08-01

4. Co-Occurrence of Differentiated Thyroid Cancer and Second Primary Malignancy: Correlation with Expression Profiles of Mismatch Repair Protein and Cell Cycle Regulators;Cancers;2021-10-31

5. Analysis of overall survival in differentiated thyroid cancer patients with double primary malignancy;The Kaohsiung Journal of Medical Sciences;2020-08-25